Report on the risk assessment of GHB in the framework of the joint action on new synthetic drugs

Emcdda — European Monitoring Centre For Drugs And Drug Addiction

Description

EMCDDA Risk assessments
Medical and biological research
Health policy
Social policy
Target audience: Scientific

Sujets

• Narcotic
• Chemical compound
• Drug
• Epidemiology
• Toxicology
• Medicine
• Social policy

Informations

• Publié par: EMCDDA-EUROPEAN-MONITORING-CENTRE-FOR-DRUGS-AND-DRUG-ADDICTION
• Nombre de lectures: 12
• Langue: English

Extrait

Report on the risk assessment of GHB in the framework of the joint action on new synthetic drugs

4

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is one of 12 decentralised agencies set up by the European Union to carry out specialised tech nical or scientific work.

The Centres main goal is to provide objective, reliable and comparable information at European level concerning drugs and drug addiction and their consequences.

Through the statistical, documentary and technical information it gathers, analyses and disseminates, the Centre provides its audience  whether policymakers, practi tioners in the drugs field or European citizens  with an overall picture of the drug phenomenon in Europe.

The Centres main tasks are: ● collecting and analysing existing data; ● improving datacomparison methods; ● disseminating data; and ● cooperating with European and international bodies and organisations, and with nonEU countries. The EMCDDA works exclusively in the field of information.

OFFICE FOR OFFICIAL PUBLICATIONS OF THE EUROPEAN COMMUNITIES  L2985 Luxembourg

I S B N9 2 - 9 1 6 8 - 1 2 2 - 9 ,!7IJ2J1gibcci! ›